Home LiteratureArticle Details
PMID: 28114292 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Gsk3 is a metabolic checkpoint regulator in B cells.

Nature immunology ·Vol. 18 ·No. 3 ·2017-00-00 ·Pages 303-312

Jellusova J, Cato MH, Apgar JR, Ramezani-Rad P, Leung CR, Chen C, Richardson AD, Conner EM, Benschop RJ, Woodgett JR, Rickert RC

Abstract

B cells predominate in a quiescent state until an antigen is encountered, which results in rapid growth, proliferation and differentiation of the B cells. These distinct cell states are probably accompanied by differing metabolic needs, yet little is known about the metabolic control of B cell fate. Here we show that glycogen synthase kinase 3 (Gsk3) is a metabolic sensor that promotes the survival of naive recirculating B cells by restricting cell mass accumulation. In antigen-driven responses, Gsk3 was selectively required for regulation of B cell size, mitochondrial biogenesis, glycolysis and production of reactive oxygen species (ROS), in a manner mediated by the co-stimulatory receptor CD40. Gsk3 was required to prevent metabolic collapse and ROS-induced apoptosis after glucose became limiting, functioning in part by repressing growth dependent on the myelocytomatosis oncoprotein c-Myc. Notably, we found that Gsk3 was required for the generation and maintenance of germinal center B cells, which require high glycolytic activity to support growth and proliferation in a hypoxic microenvironment.

MeSH Terms
Animals Antigens, CD19/genetics,metabolism Apoptosis/genetics B-Lymphocytes/physiology CD40 Ligand/metabolism Cell Differentiation Cell Proliferation Cells, Cultured Germinal Center/immunology Glycogen Synthase Kinase 3 beta/genetics,metabolism Glycolysis Interleukin-4/metabolism Mice Mice, Knockout Oxidative Stress Reactive Oxygen Species/metabolism Signal Transduction
Chemicals
Antigens, CD19 Reactive Oxygen Species CD40 Ligand Interleukin-4 Glycogen Synthase Kinase 3 beta Gsk3b protein, mouse
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Jellusova Julia
Tumor Microenvironment and Cancer Immunology Program, Sanford Burnham Prebys Medical Discovery Institute (SBP), La Jolla, California, USA. | NCI-designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA.
Cato Matthew H
Tumor Microenvironment and Cancer Immunology Program, Sanford Burnham Prebys Medical Discovery Institute (SBP), La Jolla, California, USA. | NCI-designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA.
Apgar John R
Tumor Microenvironment and Cancer Immunology Program, Sanford Burnham Prebys Medical Discovery Institute (SBP), La Jolla, California, USA. | NCI-designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA.
Ramezani-Rad Parham
Tumor Microenvironment and Cancer Immunology Program, Sanford Burnham Prebys Medical Discovery Institute (SBP), La Jolla, California, USA. | NCI-designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA.
Leung Charlotte R
Tumor Microenvironment and Cancer Immunology Program, Sanford Burnham Prebys Medical Discovery Institute (SBP), La Jolla, California, USA. | NCI-designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA.
Chen Cindi
Tumor Microenvironment and Cancer Immunology Program, Sanford Burnham Prebys Medical Discovery Institute (SBP), La Jolla, California, USA. | NCI-designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA.
Richardson Adam D
NCI-designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA.
Conner Elaine M
Eli Lilly and Company, La Jolla, California, USA.
Benschop Robert J
Eli Lilly and Company, La Jolla, California, USA.
Woodgett James R ORCID
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada. | Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
Rickert Robert C
Tumor Microenvironment and Cancer Immunology Program, Sanford Burnham Prebys Medical Discovery Institute (SBP), La Jolla, California, USA. | NCI-designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA.
References (37)
37 references, click to expand
  1. The interplay between MYC and HIF in cancer.
    Nat Rev Cancer. 2008 Jan;8(1):51-6 PMID: 18046334
  2. Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases.
    Pharmacol Ther. 2015 Apr;148:114-31 PMID: 25435019
  3. B lymphocyte-specific, Cre-mediated mutagenesis in mice.
    Nucleic Acids Res. 1997 Mar 15;25(6):1317-8 PMID: 9092650
  4. New insights into pre-BCR and BCR signalling with relevance to B cell malignancies.
    Nat Rev Immunol. 2013 Aug;13(8):578-91 PMID: 23883968
  5. Germinal Center Hypoxia Potentiates Immunoglobulin Class Switch Recombination.
    J Immunol. 2016 Nov 15;197(10 ):4014-4020 PMID: 27798169
  6. Germinal centre hypoxia and regulation of antibody qualities by a hypoxia response system.
    Nature. 2016 Sep 8;537(7619):234-238 PMID: 27501247
  7. Functional redundancy of GSK-3alpha and GSK-3beta in Wnt/beta-catenin signaling shown by using an allelic series of embryonic stem cell lines.
    Dev Cell. 2007 Jun;12 (6):957-71 PMID: 17543867
  8. The proto-oncogene MYC is required for selection in the germinal center and cyclic reentry.
    Nat Immunol. 2012 Nov;13(11):1083-91 PMID: 23001145
  9. Germinal center dynamics revealed by multiphoton microscopy with a photoactivatable fluorescent reporter.
    Cell. 2010 Nov 12;143(4):592-605 PMID: 21074050
  10. Mitochondria-ros crosstalk in the control of cell death and aging.
    J Signal Transduct. 2012;2012:329635 PMID: 22175013
  11. The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers.
    Nat Immunol. 2012 Nov;13(11):1092-100 PMID: 23001146
  12. B cell receptor signal transduction in the GC is short-circuited by high phosphatase activity.
    Science. 2012 Jun 1;336(6085):1178-81 PMID: 22555432
  13. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1.
    J Biol Chem. 1994 Sep 23;269(38):23757-63 PMID: 8089148
  14. What Are the bona fide GSK3 Substrates?
    Int J Alzheimers Dis. 2011;2011:505607 PMID: 21629754
  15. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus.
    BMC Dev Biol. 2001;1:4 PMID: 11299042
  16. MYC and metabolism on the path to cancer.
    Semin Cell Dev Biol. 2015 Jul;43:11-21 PMID: 26277543
  17. Glycogen synthase kinase 3alpha and 3beta mediate a glucose-sensitive antiapoptotic signaling pathway to stabilize Mcl-1.
    Mol Cell Biol. 2007 Jun;27(12):4328-39 PMID: 17371841
  18. Cyclin D3 is selectively required for proliferative expansion of germinal center B cells.
    Mol Cell Biol. 2011 Jan;31(1):127-37 PMID: 20956554
  19. viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia.
    Nat Biotechnol. 2013 Jun;31(6):545-52 PMID: 23685480
  20. Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A.
    Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):11960-5 PMID: 11035810
  21. When pathways collide: collaboration and connivance among signalling proteins in development.
    Nat Rev Mol Cell Biol. 2010 Jun;11(6):404-13 PMID: 20461097
  22. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B.
    Nature. 1995 Dec 21-28;378(6559):785-9 PMID: 8524413
  23. In-vitro derived germinal centre B cells differentially generate memory B or plasma cells in vivo.
    Nat Commun. 2011 Sep 06;2:465 PMID: 21897376
  24. Cutting edge: IL-4-mediated protection of primary B lymphocytes from apoptosis via Stat6-dependent regulation of glycolytic metabolism.
    J Immunol. 2007 Oct 15;179(8):4953-7 PMID: 17911579
  25. Antigen receptor-mediated changes in glucose metabolism in B lymphocytes: role of phosphatidylinositol 3-kinase signaling in the glycolytic control of growth.
    Blood. 2006 Jun 1;107(11):4458-65 PMID: 16449529
  26. TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth.
    Cell. 2006 Sep 8;126(5):955-68 PMID: 16959574
  27. Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survival.
    Blood. 2008 Jan 15;111(2):750-60 PMID: 17942753
  28. Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells.
    J Immunol. 2014 Apr 15;192(8):3626-36 PMID: 24616478
  29. Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear localization.
    J Biol Chem. 2003 Dec 19;278(51):51606-12 PMID: 14563837
  30. Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling.
    Biochem J. 1993 Nov 15;296 ( Pt 1):15-9 PMID: 8250835
  31. Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress.
    Mol Cell. 2010 Oct 22;40(2):310-22 PMID: 20965424
  32. The bulk of the peripheral B-cell pool in mice is stable and not rapidly renewed from the bone marrow.
    Proc Natl Acad Sci U S A. 1990 Jun;87(12):4781-4 PMID: 2352948
  33. GSK3-mediated raptor phosphorylation supports amino-acid-dependent mTORC1-directed signalling.
    Biochem J. 2015 Sep 1;470(2):207-21 PMID: 26348909
  34. Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis.
    Cancer Cell. 2012 Aug 14;22(2):167-79 PMID: 22897848
  35. HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity.
    Cancer Cell. 2007 May;11(5):407-20 PMID: 17482131
  36. Combined regulation of mTORC1 and lysosomal acidification by GSK-3 suppresses autophagy and contributes to cancer cell growth.
    Oncogene. 2015 Aug 27;34(35):4613-23 PMID: 25500539
  37. GSK-3β: A Bifunctional Role in Cell Death Pathways.
    Int J Cell Biol. 2012;2012:930710 PMID: 22675363
Article Info
Journal
Nature immunology
Abbr.
Nat Immunol
ISSN
1529-2916
Published
2017-00-00
Epub
2017-00-23
Pages
303-312
Language
English
Region
United States
NLM ID
100941354
PMCID
PMC5310963
Subset
IM
Grants
NCI NIH HHS · P30 CA030199 · United States
NIAID NIH HHS · R01 AI041649 · United States
CIHR · Canada
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]